{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T12:50:54Z","timestamp":1725627054887},"reference-count":16,"publisher":"The Japanese Society of Nuclear Cardiology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.17996\/anc.22-00153","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T22:09:26Z","timestamp":1656540566000},"page":"42-50","source":"Crossref","is-referenced-by-count":2,"title":["Multicenter Registry in the Japanese Cardiac Sarcoidosis Prognostic (J-CASP) Study"],"prefix":"10.17996","volume":"8","author":[{"given":"Tomoaki","family":"Nakata","sequence":"first","affiliation":[{"name":"Cardiology, Hakodate Goryoukaku Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Functional Imaging and Artificial Intelligence, Kanazawa University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanao","family":"Naya","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hokkaido University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Momose","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging and Nuclear Medicine, Tokyo Woman\u2019s Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyo","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hyogo Brain and Heart Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimitsu","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Radiology, Nihon Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Moroi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Ohashi Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsutaka","family":"Okizaki","sequence":"additional","affiliation":[{"name":"Department of Radiology, Asahikawa Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyoshi","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sapporo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatoyo","family":"Kiko","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Hida","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Takehana","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine II, Kansai Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7364","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Okada DR, Smith J, Derakhshan A, Gowani Z, Misra S, Berger RD, et al. Ventricular arrhythmias in cardiac sarcoidosis. Circulation 2018; 138: 1253\u201364.","DOI":"10.1161\/CIRCULATIONAHA.118.034687"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kazmirczak F, Chen KA, Adabag S, von Wald L, Roukoz H, Benditt DG, et al. Assessment of the 2017 AHA\/ACC\/HRS guideline recommendations for implantable cardioverter-defibrillator implantation in cardiac sarcoidosis. Circ Arrhythm Electrophysiol 2019; 12: e007488.","DOI":"10.1161\/CIRCEP.119.007488"},{"key":"3","unstructured":"3. The Japanese Circulation Society (JCS). Guidelines for the diagnosis and treatment of cardiac sarcoidosis (JCS 2016). Published on February 24, 2017 (https:\/\/www.j-circ.or.jp\/cms\/wp-content\/uploads\/2020\/02\/JCS2016_terasaki_h.pdf)"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Terasaki, F, Yoshinaga K. New guidelines for diagnosis of cardiac sarcoidosis in Japan. Ann Nucl Cardiol 2017; 3: 42\u20135.","DOI":"10.17996\/anc.17-00042"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Youssef G, Leung E, Mylonas I, Nery P, Williams K, Wisenberg G, et al: The use of <sup>18<\/sup>F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J Nucl Med 2012; 53: 241\u20138.","DOI":"10.2967\/jnumed.111.090662"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Genovesi D, Bauckneht M, Altini C, Popescu CE, Ferro P, Monaco L, et al. The role of positron emission tomography in the assessment of cardiac sarcoidosis. Br J Radiol 2019; 92: 20190247.","DOI":"10.1259\/bjr.20190247"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ishimaru S, Tsujino I, Takei T, Tsukamoto E, Sakaue S, Kamigaki M, et al. Focal uptake on <sup>18<\/sup>F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 2005; 26: 1538\u201343.","DOI":"10.1093\/eurheartj\/ehi180"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kumita S, Yoshinaga K, Miyagawa M, Momose M, Kiso K, Kasai T, et al; Committee for diagnosis of cardiac sarcoidosis using <sup>18<\/sup>F-FDG PET, Japanese Society of Nuclear Cardiology. Recommendations for <sup>18<\/sup>F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis\u20152018 update: Japanese Society of Nuclear Cardiology recommendations. J Nucl Cardiol 2019; 26: 1414\u201333.","DOI":"10.1007\/s12350-019-01755-3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Slart RHJA, Glaudemans AWJM, Gheysens O, Lubberink M, Kero T, Dweck MR, et al. Procedural recommendations of cardiac PET\/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation- (4Is) related cardiovascular diseases: a joint collaboration of the EACVI and the EANM: summary. Eur Heart J Cardiovasc Imaging 2020; 21: 1320\u201330.","DOI":"10.1093\/ehjci\/jeaa299"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Uemura A, Morimoto S, Hiramitsu S, Kato Y, Ito T, Hishida H. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 1999; 138: 299\u2013302.","DOI":"10.1016\/S0002-8703(99)70115-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Chareonthaitawee P, Beanlands RS, Chen W, Dorbala S, Miller EJ, Murthy VL, et al. Joint SNMMI-ASNC expert consensus document on the role of <sup>18<\/sup>F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Cardiol 2017; 24: 1741\u201358.","DOI":"10.1007\/s12350-017-0978-9"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Vita T, Okada DR, Veillet-Chowdhury M, Bravo PE, Mullins E, Hulten E, et al. Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis. Circ Cardiovasc Imaging 2018; 11: e007030.","DOI":"10.1161\/CIRCIMAGING.117.007030"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Fukushima K, Nagao M, Yamamoto A, Serizawa N, Ishizaki U, Suzuki A, et al. Discrepancy between significant fibrosis and active inflammation in patients with cardiac sarcoidosis: combined and image fusion analysis of cardiac magnetic resonance and <sup>18<\/sup>F fluorodeoxyglucose positron emission tomography. Eur J Hybrid Imaging 2019; 3: 9.","DOI":"10.1186\/s41824-019-0056-4"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tavora F, Cresswell N, Li L, Ripple M, Solomon C, Burke A. Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes. Am J Cardiol 2009; 104: 571\u20137.","DOI":"10.1016\/j.amjcard.2009.03.068"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sohn DW, Park JB, Lee SP, Lee SP, Kim HK, Kim YJ. Viewpoints in the diagnosis and treatment of cardiac sarcoidosis: Proposed modification of current guidelines. Clin Cardiol 2018; 41: 1386\u201394.","DOI":"10.1002\/clc.23060"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hulten E, Agarwal V, Cahill M, Cole G, Vita T, Parrish S, et al. Presence of late gadolinium enhancement by cardiac magnetic resonance among patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis: A systematic review and meta-analysis. Circ Cardiovasc Imaging 2016; 9: e005001.","DOI":"10.1161\/CIRCIMAGING.116.005001"}],"container-title":["Annals of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/anc\/8\/1\/8_22-00153\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T04:41:48Z","timestamp":1662180108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/anc\/8\/1\/8_22-00153\/_article"}},"subtitle":["Baseline Characteristics and Validation of the Non-invasive Approach Using &lt;sup&gt;18&lt;\/sup&gt;F-FDG PET"],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.17996\/anc.22-00153","relation":{},"ISSN":["2189-3926","2424-1741"],"issn-type":[{"value":"2189-3926","type":"print"},{"value":"2424-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"22-00153"}}